Ketamine Infusion for Adolescent Depression and Anxiety

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

September 28, 2018

Study Completion Date

September 30, 2019

Conditions
Major Depressive DisorderAnxiety Disorder
Interventions
DRUG

Ketamine

A single dose of 0.5mg/kg of Ketamine will be administered Intravenously during 40 minutes in the Hospital Research Unit of YNHH. The subject will be monitored continuously during the procedure, and every hour for three hours after the infusion.

DRUG

Midazolam

A single dose of 0.045mg/kg of Midazolam will be administered intravenously during 40 minutes in the Hospital Research Unit of YNHH. The subject will be monitored continuously during the procedure, and every hour for three hours after the infusion.

Trial Locations (2)

06510

Hospital Research Unit at the Yale New Haven Hospital, New Haven

06520

Yale Child Study Center, New Haven

All Listed Sponsors
collaborator

American Academy of Child Adolescent Psychiatry.

OTHER

lead

Yale University

OTHER

NCT02579928 - Ketamine Infusion for Adolescent Depression and Anxiety | Biotech Hunter | Biotech Hunter